Drug name - Jublia
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7214506 | BAUSCH | Method for treating onychomycosis |
Feb, 2026
(3 years from now) | |
| US11213519 | BAUSCH | Compositions and methods for treating diseases of the nail |
Jan, 2028
(5 years from now) | |
| US9566272 | BAUSCH | Compositions and methods for treating diseases of the nail |
Jan, 2028
(5 years from now) | |
| US9877955 | BAUSCH | Compositions and methods for treating diseases of the nail |
Jan, 2028
(5 years from now) | |
| US10512640 | BAUSCH | Compositions and methods for treating diseases of the nail |
Jan, 2028
(5 years from now) | |
| US10828369 | BAUSCH | Compositions and methods for treating diseases of the nail |
Jan, 2028
(5 years from now) | |
| US9861698 | BAUSCH | Compositions and methods for treating diseases of the nail |
Jul, 2030
(7 years from now) | |
| US8039494 | BAUSCH | Compositions and methods for treating diseases of the nail |
Jul, 2030
(7 years from now) | |
| US10105444 | BAUSCH | Compositions and methods for treating diseases of the nail |
Jul, 2030
(7 years from now) | |
| US9302009 | BAUSCH | Compositions and methods for treating diseases of the nail |
Oct, 2030
(8 years from now) | |
| US8486978 | BAUSCH | Compositions and methods for treating diseases of the nail |
Oct, 2030
(8 years from now) | |
| US10864274 | BAUSCH | Stabilized efinaconazole formulations |
Oct, 2034
(12 years from now) | |
| US9662394 | BAUSCH | Stabilized efinaconazole compositions |
Oct, 2034
(12 years from now) | |
| US10342875 | BAUSCH | Stabilized efinaconazole compositions |
Oct, 2034
(12 years from now) | |
| US10828293 | BAUSCH | Anti-infective methods, compositions, and devices |
Oct, 2034
(12 years from now) | |
| US10478601 | BAUSCH | Applicator |
Apr, 2035
(12 years from now) | |
Drugs and Companies using EFINACONAZOLE ingredient
Treatment: Antimycotic uses, specifically treatment of onychomycosis; Antimycotic uses, specifically treatment of onychomycosis; topical treatment of the toenail(s) due to trichophyton rubrum and trichophyton mentagrophytes; Topical treatment of onychomycosis of the toenail(s) due to trichophyton rubrum and trichophyton mentagrophytes; Topical treatment of tinea unguium by using an applicator for applying a solution for treating tinea unguium to an affected part of a patient
Dosage: SOLUTION;TOPICAL
| Strength | Dosage | Availability |
|---|---|---|
| 10% | SOLUTION;TOPICAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.